Going from one field to the next can be a tricky thing to navigate. In this episode of Trends from the Trenches, host Stan Gloss speaks with Tom Miller, Co-Founder and CEO of Iambic Therapeutics, about his journey from academia as a professor at the California Institute of Technology to getting B-Round funding as the CEO of his own start-up. Miller discusses why he started his company, what inspired him to turn his research into an entrepreneurial venture, and how combining physics and data can create more data-efficient AI algorithms that vastly improve accuracy in prediction models. Miller also shares advice and insights for academic researchers on taking their discoveries and bringing them to the market. 

Links from this episode:  

Bio-IT World
BioTeam
Bio-IT World Europe
Iambic Therapeutics 

Trends from the Trenches boiler: Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.